69 research outputs found

    Optimum Power Output Control of a Wind Turbine Rotor

    Get PDF
    © 2016 S. Wijewardana et al. An active and optimum controller is applied to regulate the power output from a wind turbine rotor. The controller is synthesized in two steps. The first step defines the equilibrium operation point and ensures that the desired equilibrium point is stable. The stability of the equilibrium point is guaranteed by a control law that is synthesized by applying the methodology of model predictive control (MPC). The method of controlling the turbine involves pitching the turbine blades. In the second step the blade pitch angle demand is defined. This involves minimizing the mean square error between the actual and desired power coefficient. The actual power coefficient of the wind turbine rotor is evaluated assuming that the blade is capable of stalling, using blade element momentum theory. This ensures that the power output of the rotor can be reduced to any desired value which is generally not possible unless a nonlinear stall model is introduced to evaluate the blade profile coefficients of lift and drag. The relatively simple and systematic nonlinear modelling and MPC controller synthesis approach adopted in this paper clearly highlights the main features on the controller that is capable of regulating the power output of the wind turbine rotor

    Human Flt3L Generates Dendritic Cells from Canine Peripheral Blood Precursors: Implications for a Dog Glioma Clinical Trial

    Get PDF
    Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults and carries a dismal prognosis. We have developed a conditional cytotoxic/immunotherapeutic approach using adenoviral vectors (Ads) encoding the immunostimulatory cytokine, human soluble fms-like tyrosine kinase 3 ligand (hsFlt3L) and the conditional cytotoxic molecule, i.e., Herpes Simplex Type 1- thymide kinase (TK). This therapy triggers an anti-tumor immune response that leads to tumor regression and anti-tumor immunological memory in intracranial rodent cancer models. We aim to test the efficacy of this immunotherapy in dogs bearing spontaneous GBM. In view of the controversy regarding the effect of human cytokines on dog immune cells, and considering that the efficacy of this treatment depends on hsFlt3L-stimulated dendritic cells (DCs), in the present work we tested the ability of Ad-encoded hsFlt3L to generate DCs from dog peripheral blood and compared its effects with canine IL-4 and GM-CSF.Our results demonstrate that hsFlT3L expressed form an Ad vector, generated DCs from peripheral blood cultures with very similar morphological and phenotypic characteristics to canine IL-4 and GM-CSF-cultured DCs. These include phagocytic activity and expression of CD11c, MHCII, CD80 and CD14. Maturation of DCs cultured under both conditions resulted in increased secretion of IL-6, TNF-alpha and IFN-gamma. Importantly, hsFlt3L-derived antigen presenting cells showed allostimulatory potential highlighting their ability to present antigen to T cells and elicit their proliferation.These results demonstrate that hsFlt3L induces the proliferation of canine DCs and support its use in upcoming clinical trials for canine GBM. Our data further support the translation of hsFlt3L to be used for dendritic cells' vaccination and gene therapeutic approaches from rodent models to canine patients and its future implementation in human clinical trials

    Early Myeloid Dendritic Cell Dysregulation is Predictive of Disease Progression in Simian Immunodeficiency Virus Infection

    Get PDF
    Myeloid dendritic cells (mDC) are lost from blood in individuals with human immunodeficiency virus (HIV) infection but the mechanism for this loss and its relationship to disease progression are not known. We studied the mDC response in blood and lymph nodes of simian immunodeficiency virus (SIV)-infected rhesus macaques with different disease outcomes. Early changes in blood mDC number were inversely correlated with virus load and reflective of eventual disease outcome, as animals with stable infection that remained disease-free for more than one year had average increases in blood mDC of 200% over preinfection levels at virus set-point, whereas animals that progressed rapidly to AIDS had significant loss of mDC at this time. Short term antiretroviral therapy (ART) transiently reversed mDC loss in progressor animals, whereas discontinuation of ART resulted in a 3.5-fold increase in mDC over preinfection levels only in stable animals, approaching 10-fold in some cases. Progressive SIV infection was associated with increased CCR7 expression on blood mDC and an 8-fold increase in expression of CCL19 mRNA in lymph nodes, consistent with increased mDC recruitment. Paradoxically, lymph node mDC did not accumulate in progressive infection but rather died from caspase-8-dependent apoptosis that was reduced by ART, indicating that increased recruitment is offset by increased death. Lymph node mDC from both stable and progressor animals remained responsive to exogenous stimulation with a TLR7/8 agonist. These data suggest that mDC are mobilized in SIV infection but that an increase in the CCR7-CCL19 chemokine axis associated with high virus burden in progressive infection promotes exodus of activated mDC from blood into lymph nodes where they die from apoptosis. We suggest that inflamed lymph nodes serve as a sink for mDC through recruitment, activation and death that contributes to AIDS pathogenesis

    SIVagm Infection in Wild African Green Monkeys from South Africa: Epidemiology, Natural History, and Evolutionary Considerations

    Get PDF
    Pathogenesis studies of SIV infection have not been performed to date in wild monkeys due to difficulty in collecting and storing samples on site and the lack of analytical reagents covering the extensive SIV diversity. We performed a large scale study of molecular epidemiology and natural history of SIVagm infection in 225 free-ranging AGMs from multiple locations in South Africa. SIV prevalence (established by sequencing pol, env, and gag) varied dramatically between infant/juvenile (7%) and adult animals (68%) (p<0.0001), and between adult females (78%) and males (57%). Phylogenetic analyses revealed an extensive genetic diversity, including frequent recombination events. Some AGMs harbored epidemiologically linked viruses. Viruses infecting AGMs in the Free State, which are separated from those on the coastal side by the Drakensberg Mountains, formed a separate cluster in the phylogenetic trees; this observation supports a long standing presence of SIV in AGMs, at least from the time of their speciation to their Plio-Pleistocene migration. Specific primers/probes were synthesized based on the pol sequence data and viral loads (VLs) were quantified. VLs were of 104-106 RNA copies/ml, in the range of those observed in experimentally-infected monkeys, validating the experimental approaches in natural hosts. VLs were significantly higher (107-108 RNA copies/ml) in 10 AGMs diagnosed as acutely infected based on SIV seronegativity (Fiebig II), which suggests a very active transmission of SIVagm in the wild. Neither cytokine levels (as biomarkers of immune activation) nor sCD14 levels (a biomarker of microbial translocation) were different between SIV-infected and SIV-uninfected monkeys. This complex algorithm combining sequencing and phylogeny, VL quantification, serology, and testing of surrogate markers of microbial translocation and immune activation permits a systematic investigation of the epidemiology, viral diversity and natural history of SIV infection in wild African natural hosts. © 2013 Ma et al

    Environmental effects of ozone depletion, UV radiation and interactions with climate change : UNEP Environmental Effects Assessment Panel, update 2017

    Get PDF
    Peer reviewe

    Hyperhemolysis in a patient with &#946;-thalassemia major

    No full text
    A case of hyperhemolysis in a 2-year-old boy with &#946; thalassemia major was noted. After several transfusions, he developed hyperhemolysis with a positive (C3d only) direct antiglobulin test (DAT) and no clinically significant RBC allo- or auto-antibodies. (There was a weak cold antibody, showing a narrow thermal range). Because there was no significant improvement with steroid and immunoglobulin infusions, cyclophosphamide therapy was tried with notable success

    Vaccine Breakthrough COVID-19 Outbreak in Section of a Hospital with 88% Attack Rate: Lessons to Be Learned

    No full text
    Vaccine breakthrough COVID-19 clusters with high attack rates are very rare. They paralyze affected section/s of the institution; thus, awareness of them is important. This is an analysis of a vaccine breakthrough COVID-19 cluster with an 88% attack rate involving 35 security guards (SGs) of the Teaching Hospital-Peradeniya, Sri Lanka. The identification of the particular combination of factors that resulted in this outbreak’s 88% attack rate was our main objective, because this knowledge is useful to prevent similar clusters of COVID-19 and other similar infections. We traced and documented contact details, risky behaviors, and medical history of all SGs. Contacts of all COVID-19 cases were tested for COVID-19. We created an epi-curve and identified the index case (IC). The epi-curve pattern indicates a propagated source outbreak. No SG was seriously immunocompromised. There was no breach in the local cold chain. The following combination of factors synergistically created this outbreak: communal meals at cramped spaces, unfamiliarity with vaccine breakthrough cases, disregard of the risk of infection from fully vaccinated coworkers, hesitancy to report COVID-19-like symptoms early on, symptomatic treatment of COVID-19-like patients without testing for COVID-19, permission to return home, and the Alpha variant of the SARS-CoV-2 virus
    • …
    corecore